Eli Lilly, Verve Therapeutics receive early termination from US FTC
MLex Summary: Eli Lilly and Verve Therapeutics were granted early termination by the US Federal Trade Commission today, according to a securities filing. The companies agreed to their $1 billion deal...To view the full article, register now.
Already a subscriber? Click here to view full article